ANDA 65094, held by Impax Laboratories. Demeclocycline Hydrochloride.
As of Nov 21, 2026, ANDA 65094 (Demeclocycline Hydrochloride), held by Impax Laboratories, was first approved by FDA on Mar 22, 2004, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 22, 2004 | Original application | Approved | None posted |
| Demeclocycline Hydrochloride150MG · tablet;oral | Demeclocycline Hydrochloride | Discontinued |
| Demeclocycline Hydrochloride300MG · tablet;oral | Demeclocycline Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters